| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $166.8M | -19.0% |
| R&D Expense | $192.1M | +30.0% |
| SG&A Expense | $52.9M | +14.8% |
| Operating Income | -$78.2M | -742.2% |
| Pre-tax Income | -$27.9M | -362.0% |
| Income Tax | $1.8M | +41.7% |
| Net Income | -$29.7M | -417.9% |
| EPS (Basic) | -$1.12 | -420.0% |
| EPS (Diluted) | -$1.12 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $292.0M | -25.5% |
| Accounts Receivable | $32.1M | +1060.1% |
| Current Assets | $386.6M | -4.2% |
| Total Assets | $429.4M | -4.7% |
| Current Liabilities | $82.0M | -35.4% |
| Total Liabilities | $150.9M | -16.2% |
| Stockholders' Equity | $278.5M | +3.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.1M | -156.6% |
| Capital Expenditures | $2.9M | -62.5% |
| Investing Cash Flow | -$2.9M | +62.5% |
| Financing Cash Flow | -$24.1M | -742.5% |
| Free Cash Flow | -$21.0M | -186.5% |
| -420.0% |